Company profile for Sensorion

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sensorion is a biopharmaceutical company, formed in 2009, focused as a “pure player” on developing therapies for debilitating inner ear disorders. With our primary strength in the inner ear and neurosciences, we combine world-class scientific excellence and top-tier execution capabilities to deliver first-in-class therapeutics. Sensorion was initially founded by French and European academics, and has now diversified its co...
Sensorion is a biopharmaceutical company, formed in 2009, focused as a “pure player” on developing therapies for debilitating inner ear disorders. With our primary strength in the inner ear and neurosciences, we combine world-class scientific excellence and top-tier execution capabilities to deliver first-in-class therapeutics. Sensorion was initially founded by French and European academics, and has now diversified its core competencies by recruiting a network of partners and key opinion leaders. Our leadership has exceptional, solid experience in research, marketing and finance.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
375, rue du Professeur Joseph Blayac 34080 MONTPELLIER
Telephone
Telephone
+33 (0)4 67 20 77 30
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250814814164/en/Sensorion-Announces-an-Increase-in-Resources-Allocated-to-the-Liquidity-Contract-with-Kepler-Cheuvreux

BUSINESSWIRE
15 Aug 2025

https://www.businesswire.com/news/home/20250731498899/en/Sensorion-Announces-Its-Participation-In-Upcoming-Investor-Conferences

BUSINESSWIRE
31 Jul 2025

https://www.businesswire.com/news/home/20250728154446/en/Sensorion-Completes-Patient-Enrollment-of-the-Second-Cohort-in-Audiogene-Phase-12-Gene-Therapy-Clinical-Trial

BUSINESSWIRE
29 Jul 2025

https://www.businesswire.com/news/home/20250630685258/en/Sensorion-Announces-Preliminary-Positive-Data-from-the-First-Cohort-of-the-Audiogene-Phase-12-Gene-Therapy-Clinical-Trial

BUSINESSWIRE
01 Jul 2025

https://www.businesswire.com/news/home/20250512858280/en/Sensorion-Publishes-Results-of-Combined-Shareholders-General-Meeting-Resolutions

BUSINESSWIRE
13 May 2025

https://www.businesswire.com/news/home/20250505759761/en/Sensorion-Announces-its-Participation-in-the-American-Society-of-Cell-and-Gene-Therapy-ASGCT-Annual-Meeting

BUSINESSWIRE
06 May 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty